Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review
2019 · BMC Cancer · 58 citations
https://doi.org/10.1186/s12885-019-6236-6
Y
Yukinori Ozaki
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
146
Papers
826
Citations
16
h-index
24
i10-index
Yukinori Ozaki is an academic researcher from The Cancer Institute Hospital. The author has contributed to research in topics: Advanced Breast Cancer Therapies & Cancer Immunotherapy and Biomarkers & Cancer Treatment and Pharmacology. The author has an h-index of 16, co-authored 125 publications.
ORCID: 0000-0002-8064-648XPapers by this author
worksThe Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition
2023 · Breast Cancer · 53 citations
https://doi.org/10.1007/s12282-023-01505-x
Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan
2018 · ESMO Open · 33 citations
https://doi.org/10.1136/esmoopen-2017-000301
Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer: Primary results and biomarker data from a phase 2 trial (WJOG9917B)
2022 · European Journal of Cancer · 31 citations
https://doi.org/10.1016/j.ejca.2022.05.014
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report
2017 · BMC Cancer · 24 citations
https://doi.org/10.1186/s12885-017-3785-4
Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer
2022 · Breast Cancer Research and Treatment · 21 citations
https://doi.org/10.1007/s10549-022-06726-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat